BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31428418)

  • 1. Differences in the prognostic value of tumor size on hepatocellular cancer-specific survival stratified by gender in a SEER population-based study.
    Zhang W; Jin K; Wang F; Zhangyuan G; Yu W; Liu Y; Zhang H; Zhang P; Sun B
    United European Gastroenterol J; 2019 Aug; 7(7):933-941. PubMed ID: 31428418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of marital status on stage at diagnosis in hepatocellular carcinoma.
    Zhang W; Wang X; Huang R; Jin K; Zhangyuan G; Yu W; Yin Y; Wang H; Xu Z; Sun B
    Sci Rep; 2017 Jan; 7():41695. PubMed ID: 28139708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Tumor Size on Cancer-Specific Survival in Small Hepatocellular Carcinoma.
    Zhang W; Wang X; Jiang R; Hou J; Mu X; Li G; Sun B
    Mayo Clin Proc; 2015 Sep; 90(9):1187-95. PubMed ID: 26231292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited.
    Chen YL; Ko CJ; Chien SY; Chen LS; Chen ML; Chi CW; Lai HW
    J Gastroenterol Hepatol; 2011 May; 26(5):851-7. PubMed ID: 21129015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
    Bian X; He X; Yang L; Wu W; Li L
    Dig Dis Sci; 2020 Jul; 65(7):2140-2147. PubMed ID: 31673904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database.
    Huang B; Feng Y; Zhu L; Xu T; Huang L; Cai G
    Int J Surg; 2016 Sep; 33 Pt A():157-63. PubMed ID: 27491969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA.
    El-Fattah MA
    Indian J Gastroenterol; 2017 Mar; 36(2):117-125. PubMed ID: 28194604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features and prognostic factors of young patients with surgically treated liver cancer.
    Zhang W; Jiang R; Hou J; Sun B
    Medicine (Baltimore); 2015 Mar; 94(12):e684. PubMed ID: 25816040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
    Mironov O; Jaberi A; Kachura JR
    J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint.
    Groeschl RT; Gamblin TC; Turaga KK
    Ann Surg Oncol; 2013 Oct; 20(11):3591-5. PubMed ID: 23720072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.
    Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H
    BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
    Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
    J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does fibrosis have an impact on survival of patients with hepatocellular carcinoma: evidence from the SEER database?
    Liu H; Cen D; Yu Y; Wang Y; Liang X; Lin H; Cai X
    BMC Cancer; 2018 Nov; 18(1):1125. PubMed ID: 30445928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The power of tumor sizes in predicting the survival of solitary hepatocellular carcinoma patients.
    Yang A; Xiao W; Chen D; Wei X; Huang S; Lin Y; Zhang C; Lin J; Deng F; Wu C; He X
    Cancer Med; 2018 Dec; 7(12):6040-6050. PubMed ID: 30430769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of marital status on the survival of patients with hepatocellular carcinoma treated with surgical resection: an analysis of 13,408 patients in the surveillance, epidemiology, and end results (SEER) database.
    Wu C; Chen P; Qian JJ; Jin SJ; Yao J; Wang XD; Bai DS; Jiang GQ
    Oncotarget; 2016 Nov; 7(48):79442-79452. PubMed ID: 27769053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
    Zhu Q; Yuan B; Qiao GL; Yan JJ; Li Y; Duan R; Yan YQ
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):418-27. PubMed ID: 26823044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.